JOSE L MENDOZA
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology
- Where
- BRANDYWINE, MD
- NPI
- 1982648036
- Received
- $38,747 in 635 records, 2019 to 2025 ($38,709 general, $38 research)
- As principal investigator
- $282,571 of research payments to others in 21 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 119 | $8,695 |
| 2024 | General payment | 127 | $14,216 |
| 2023 | General payment | 146 | $3,404 |
| 2022 | General payment | 110 | $5,092 |
| 2021 | General payment | 8 | $156 |
| 2021 | Research payment | 1 | $38 |
| 2020 | General payment | 21 | $1,462 |
| 2019 | General payment | 103 | $5,680 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Consulting Fee | 10 | $16,510 |
| Food and Beverage | 601 | $14,281 |
| Travel and Lodging | 12 | $4,405 |
| Honoraria | 3 | $2,250 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 1 | $1,000 |
| Education | 7 | $262 |
| Research payment | 1 | $38 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-30 | TAIHO ONCOLOGY, INC. | $29 | Food and Beverage | In-kind items and services | LONSURF Drug, Oncology | 2025 | |
| 2025-12-15 | Takeda Pharmaceuticals U.S.A., Inc. | $34 | Food and Beverage | In-kind items and services | FRUZAQLA Drug, ONCOLOGY | 2025 | |
| 2025-12-08 | Astellas Pharma US Inc | $30 | Food and Beverage | In-kind items and services | Padcev Drug, Oncology | 2025 | |
| 2025-12-03 | Janssen Biotech, Inc. | $29 | Food and Beverage | In-kind items and services | TECVAYLI Biological, Oncology | 2025 | |
| 2025-12-01 | Janssen Biotech, Inc. | $24 | Food and Beverage | In-kind items and services | TECVAYLI Biological, Oncology | 2025 | |
| 2025-11-26 | EMD Serono, Inc. | $28 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-11-24 | Pharmacosmos Therapeutics Inc. | $34 | Food and Beverage | In-kind items and services | MONOFERRIC Drug, HEMATOLOGY | 2025 | |
| 2025-11-21 | Merck Sharp & Dohme LLC | $19 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-11-19 | Spectrum Pharmaceuticals Inc. | $23 | Food and Beverage | In-kind items and services | ROLVEDON Drug, Oncology | 2025 | |
| 2025-11-17 | Novartis Pharmaceuticals Corporation | $28 | Food and Beverage | In-kind items and services | LUTATHERA Drug, Oncology | 2025 | |
| 2025-11-11 | ABBVIE INC. | $31 | Food and Beverage | In-kind items and services | IMBRUVICA Drug, ONCOLOGY | 2025 | |
| 2025-11-10 | Bayer Healthcare Pharmaceuticals Inc. | $26 | Food and Beverage | In-kind items and services | Nubeqa Drug, Oncology | 2025 | |
| 2025-11-03 | Merck Sharp & Dohme LLC | $34 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-10-31 | AstraZeneca Pharmaceuticals LP | $33 | Food and Beverage | In-kind items and services | IMFINZI Biological, Oncology | 2025 | |
| 2025-10-29 | PFIZER INC. | $28 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2025 | |
| 2025-10-27 | Sumitomo Pharma America, Inc. | $20 | Food and Beverage | In-kind items and services | ORGOVYX Drug, PROSTATE CANCER | 2025 | |
| 2025-10-24 | Cycle Pharmaceuticals Inc | $22 | Food and Beverage | Cash or cash equivalent | Phyrago Drug, Oncology | 2025 | |
| 2025-10-24 | Janssen Biotech, Inc. | $6 | Food and Beverage | In-kind items and services | TECVAYLI Biological, Oncology | 2025 | |
| 2025-10-23 | Janssen Biotech, Inc. | $15 | Food and Beverage | In-kind items and services | TECVAYLI Biological, Oncology | 2025 | |
| 2025-10-22 | Genentech USA, Inc. | $23 | Food and Beverage | In-kind items and services | Tecentriq Biological, BioOncology | 2025 | |
| 2025-10-21 | SOBI, INC | $17 | Food and Beverage | In-kind items and services | Vonjo Drug, Hematology/Oncology | 2025 | |
| 2025-10-20 | Merck Sharp & Dohme LLC | $23 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-10-17 | PharmaEssentia USA Corporation | $32 | Food and Beverage | In-kind items and services | BESREMI Drug, Oncology | 2025 | |
| 2025-10-07 | Novartis Pharmaceuticals Corporation | $18 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-10-07 | Novartis Pharmaceuticals Corporation | $0 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-10-03 | Genentech USA, Inc. | $26 | Food and Beverage | In-kind items and services | Polivy Biological, BioOncology | 2025 | |
| 2025-10-03 | Takeda Pharmaceuticals U.S.A., Inc. | $18 | Food and Beverage | In-kind items and services | FRUZAQLA Drug, ONCOLOGY | 2025 | |
| 2025-10-01 | Geron Corporation | $24 | Food and Beverage | In-kind items and services | RYTELO Drug, MYELODYSPLASTIC SYNDROME | 2025 | |
| 2025-09-29 | Regeneron Healthcare Solutions, Inc. | $26 | Food and Beverage | In-kind items and services | LYNOZYFIC Biological, HEMATOLOGY AND ONCOLOGY | 2025 | |
| 2025-09-29 | Caris MPI, Inc. | $20 | Food and Beverage | In-kind items and services | MI CANCER SEEK Device, ONCOLOGY | 2025 | |
| 2025-09-26 | Janssen Biotech, Inc. | $41 | Food and Beverage | In-kind items and services | TALVEY Biological, Oncology | 2025 | |
| 2025-09-22 | Novartis Pharmaceuticals Corporation | $6 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-09-19 | SOBI, INC | $34 | Food and Beverage | In-kind items and services | Vonjo Drug, Hematology/Oncology | 2025 | |
| 2025-09-17 | Legend Biotech USA Inc. | $23 | Food and Beverage | In-kind items and services | CARVYKTI Biological, Oncology | 2025 | |
| 2025-09-15 | Novartis Pharmaceuticals Corporation | $28 | Food and Beverage | In-kind items and services | PLUVICTO Drug, Oncology | 2025 | |
| 2025-09-10 | SOBI, INC | $34 | Food and Beverage | In-kind items and services | Vonjo Drug, Hematology/Oncology | 2025 | |
| 2025-09-08 | Aveo Pharmaceuticals, Inc. | $35 | Food and Beverage | In-kind items and services | FOTIVDA Drug, Oncology | 2025 | |
| 2025-08-29 | BeOne Medicines USA, Inc. | $32 | Food and Beverage | In-kind items and services | BRUKINSA Drug, Oncology | 2025 | |
| 2025-08-25 | Merck Sharp & Dohme LLC | $31 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-08-20 | Acrotech Biopharma Inc. | $15 | Food and Beverage | In-kind items and services | BELEODAQ Drug, ONCOLOGY | 2025 | |
| 2025-08-18 | Janssen Biotech, Inc. | $17 | Food and Beverage | In-kind items and services | ERLEADA Drug, Oncology | 2025 | |
| 2025-08-15 | AstraZeneca Pharmaceuticals LP | $39 | Food and Beverage | In-kind items and services | LYNPARZA Drug, Oncology | 2025 | |
| 2025-08-08 | ABBVIE INC. | $32 | Food and Beverage | In-kind items and services | IMBRUVICA Drug, ONCOLOGY | 2025 | |
| 2025-08-08 | PUMA BIOTECHNOLOGY, INC. | $19 | Food and Beverage | In-kind items and services | NERLYNX Drug, ONCOLOGY | 2025 | |
| 2025-08-06 | Novartis Pharmaceuticals Corporation | $34 | Food and Beverage | In-kind items and services | Fabhalta Drug, Immunology | 2025 | |
| 2025-07-30 | E.R. Squibb & Sons, L.L.C. | $23 | Food and Beverage | Cash or cash equivalent | ELIQUIS Drug, Cardiovascular | 2025 | |
| 2025-07-28 | PFIZER INC. | $21 | Food and Beverage | In-kind items and services | ELREXFIO Drug, ONCOLOGY | 2025 | |
| 2025-07-25 | Karyopharm Therapeutics Inc. | $2,223 | Travel and Lodging | Cash or cash equivalent | XPOVIO Drug, Oncology | 2025 | |
| 2025-07-25 | Karyopharm Therapeutics Inc. | $50 | Food and Beverage | In-kind items and services | XPOVIO Drug, Oncology | 2025 | |
| 2025-07-25 | Karyopharm Therapeutics Inc. | $49 | Travel and Lodging | In-kind items and services | XPOVIO Drug, Oncology | 2025 | |
| 2025-07-25 | Karyopharm Therapeutics Inc. | $34 | Food and Beverage | In-kind items and services | XPOVIO Drug, Oncology | 2025 | |
| 2025-07-25 | PharmaEssentia USA Corporation | $33 | Food and Beverage | In-kind items and services | BESREMI Drug, Oncology | 2025 | |
| 2025-07-23 | Daiichi Sankyo Inc. | $27 | Food and Beverage | In-kind items and services | DATROWAY Drug, ONCOLOGY | 2025 | |
| 2025-07-22 | Incyte Corporation | $24 | Food and Beverage | Cash or cash equivalent | ZYNYZ Drug, Oncology | 2025 | |
| 2025-07-16 | ABBVIE INC. | $33 | Food and Beverage | In-kind items and services | IMBRUVICA Drug, ONCOLOGY | 2025 | |
| 2025-07-14 | EMD Serono, Inc. | $21 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-07-11 | PFIZER INC. | $22 | Food and Beverage | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2025 | |
| 2025-07-09 | Astellas Pharma US Inc | $28 | Food and Beverage | In-kind items and services | Vyloy Drug, Oncology | 2025 | |
| 2025-06-27 | EMD Serono, Inc. | $19 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-06-25 | Merck Sharp & Dohme LLC | $14 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-06-23 | SOBI, INC | $27 | Food and Beverage | In-kind items and services | Vonjo Drug, Hematology/Oncology | 2025 | |
| 2025-06-20 | Bayer Healthcare Pharmaceuticals Inc. | $33 | Food and Beverage | In-kind items and services | Nubeqa Drug, Oncology | 2025 | |
| 2025-06-16 | Azurity Pharmaceuticals, Inc. | $21 | Food and Beverage | In-kind items and services | DANZITEN Drug, ONCOLOGY | 2025 | |
| 2025-06-11 | Janssen Biotech, Inc. | $42 | Food and Beverage | In-kind items and services | TALVEY Biological, Oncology | 2025 | |
| 2025-06-10 | AstraZeneca Pharmaceuticals LP | $28 | Food and Beverage | In-kind items and services | CALQUENCE Drug, Oncology | 2025 | |
| 2025-06-10 | AstraZeneca Pharmaceuticals LP | $1 | Food and Beverage | In-kind items and services | CALQUENCE Drug, Oncology | 2025 | |
| 2025-06-06 | Novartis Pharmaceuticals Corporation | $28 | Food and Beverage | In-kind items and services | LUTATHERA Drug, Oncology | 2025 | |
| 2025-06-04 | Immunocore Limited | $38 | Food and Beverage | In-kind items and services | KIMMTRAK Drug, Oncology | 2025 | |
| 2025-06-03 | AstraZeneca Pharmaceuticals LP | $24 | Food and Beverage | In-kind items and services | LYNPARZA Drug, Oncology | 2025 | |
| 2025-06-02 | GlaxoSmithKline, LLC. | $34 | Food and Beverage | In-kind items and services | JEMPERLI Biological, ONCOLOGY | 2025 | |
| 2025-05-23 | Agios Pharmaceuticals, Inc. | $29 | Food and Beverage | In-kind items and services | PYRUKYND Drug, Genetically Defined Disease | 2025 | |
| 2025-05-21 | AstraZeneca Pharmaceuticals LP | $1,675 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-05-21 | Merck Sharp & Dohme LLC | $25 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-05-19 | PFIZER INC. | $25 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2025 | |
| 2025-05-16 | ARRAY BIOPHARMA INC | $13 | Food and Beverage | In-kind items and services | LORBRENA Drug, ONCOLOGY | 2025 | |
| 2025-05-14 | GENZYME CORPORATION | $25 | Food and Beverage | In-kind items and services | SARCLISA Biological, Oncology | 2025 | |
| 2025-05-12 | Bayer Healthcare Pharmaceuticals Inc. | $117 | Food and Beverage | In-kind items and services | Nubeqa Drug, Oncology | 2025 | |
| 2025-05-02 | PharmaEssentia USA Corporation | $31 | Food and Beverage | In-kind items and services | BESREMI Drug, Oncology | 2025 | |
| 2025-04-30 | Daiichi Sankyo Inc. | $29 | Food and Beverage | In-kind items and services | INJECTAFER Drug, Iron Deficiency Anemia | 2025 | |
| 2025-04-28 | PFIZER INC. | $17 | Food and Beverage | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2025 | |
| 2025-04-25 | Spectrum Pharmaceuticals Inc. | $22 | Food and Beverage | In-kind items and services | ROLVEDON Drug, Oncology | 2025 | |
| 2025-04-23 | Janssen Biotech, Inc. | $21 | Food and Beverage | In-kind items and services | RYBREVANT Drug, Oncology | 2025 | |
| 2025-04-23 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | IMBRUVICA Drug, ONCOLOGY | 2025 | |
| 2025-04-22 | PFIZER INC. | $29 | Food and Beverage | In-kind items and services | TIVDAK Biological, ONCOLOGY | 2025 | |
| 2025-04-18 | PUMA BIOTECHNOLOGY, INC. | $13 | Food and Beverage | In-kind items and services | NERLYNX Drug, ONCOLOGY | 2025 | |
| 2025-04-16 | AstraZeneca Pharmaceuticals LP | $32 | Food and Beverage | In-kind items and services | IMFINZI Biological, Oncology | 2025 | |
| 2025-04-07 | Syndax Pharmaceuticals, Inc. | $29 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-04-04 | AstraZeneca Pharmaceuticals LP | $29 | Food and Beverage | In-kind items and services | ENHERTU Biological, Oncology | 2025 | |
| 2025-04-02 | Janssen Biotech, Inc. | $27 | Food and Beverage | In-kind items and services | DARZALEX Biological, Oncology | 2025 | |
| 2025-03-28 | Genentech USA, Inc. | $24 | Food and Beverage | In-kind items and services | Venclexta Biological, BioOncology | 2025 | |
| 2025-03-27 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | IMBRUVICA Drug, ONCOLOGY | 2025 | |
| 2025-03-24 | Takeda Pharmaceuticals U.S.A., Inc. | $35 | Food and Beverage | In-kind items and services | FRUZAQLA Drug, ONCOLOGY | 2025 | |
| 2025-03-18 | Immunocore Limited | $21 | Food and Beverage | In-kind items and services | KIMMTRAK Drug, Oncology | 2025 | |
| 2025-03-17 | Incyte Corporation | $27 | Food and Beverage | Cash or cash equivalent | MONJUVI Drug, Oncology | 2025 | |
| 2025-03-17 | Bayer Healthcare Pharmaceuticals Inc. | $10 | Food and Beverage | In-kind items and services | Kerendia Drug, Cardio-Renal | 2025 | |
| 2025-03-15 | TAIHO ONCOLOGY, INC. | $24 | Food and Beverage | In-kind items and services | LONSURF Drug, Oncology | 2025 | |
| 2025-03-10 | Kite Pharma, Inc. | $24 | Food and Beverage | In-kind items and services | Yescarta Drug, CELLT | 2025 | |
| 2025-03-07 | Aveo Pharmaceuticals, Inc. | $26 | Food and Beverage | In-kind items and services | FOTIVDA Drug, Oncology | 2025 | |
| 2025-03-05 | Novartis Pharmaceuticals Corporation | $27 | Food and Beverage | In-kind items and services | PLUVICTO Drug, Oncology | 2025 | |
| 2025-03-05 | Novartis Pharmaceuticals Corporation | $21 | Food and Beverage | In-kind items and services | SCEMBLIX Drug, Oncology | 2025 | |
| 2025-03-03 | Merck Sharp & Dohme LLC | $24 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-02-28 | Merck Sharp & Dohme LLC | $26 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-02-24 | KYOWA KIRIN, INC. | $23 | Food and Beverage | In-kind items and services | POTELIGEO Drug, MONOCLONAL ANTIBODY | 2025 | |
| 2025-02-21 | Takeda Pharmaceuticals U.S.A., Inc. | $24 | Food and Beverage | In-kind items and services | FRUZAQLA Drug, ONCOLOGY | 2025 | |
| 2025-02-21 | Genentech USA, Inc. | $22 | Food and Beverage | In-kind items and services | Polivy Biological, BioOncology | 2025 | |
| 2025-02-19 | ARRAY BIOPHARMA INC | $36 | Food and Beverage | In-kind items and services | BRAFTOVI Drug, ONCOLOGY | 2025 | |
| 2025-02-17 | Novartis Pharmaceuticals Corporation | $31 | Food and Beverage | In-kind items and services | Fabhalta Drug, Immunology | 2025 | |
| 2025-02-17 | SOBI, INC | $28 | Food and Beverage | In-kind items and services | Doptelet Drug, Hematology/Oncology | 2025 | |
| 2025-02-14 | E.R. Squibb & Sons, L.L.C. | $34 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-02-14 | PFIZER INC. | $1 | Food and Beverage | In-kind items and services | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | 2025 | |
| 2025-02-10 | Gilead Sciences, Inc. | $23 | Food and Beverage | In-kind items and services | Trodelvy Drug, ONC | 2025 | |
| 2025-02-05 | Regeneron Healthcare Solutions, Inc. | $32 | Food and Beverage | In-kind items and services | LIBTAYO Biological, ONCOLOGY | 2025 | |
| 2025-02-03 | Merck Sharp & Dohme LLC | $29 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-01-27 | Merck Sharp & Dohme LLC | $27 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-01-25 | AstraZeneca Pharmaceuticals LP | $1,675 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-01-24 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | VENCLEXTA Drug, ONCOLOGY | 2025 | |
| 2025-01-13 | ABBVIE INC. | $34 | Food and Beverage | In-kind items and services | IMBRUVICA Drug, ONCOLOGY | 2025 | |
| 2025-01-08 | Pharmacosmos Therapeutics Inc. | $28 | Food and Beverage | In-kind items and services | MONOFERRIC Drug, HEMATOLOGY | 2025 | |
| 2025-01-08 | PFIZER INC. | $17 | Food and Beverage | In-kind items and services | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | 2025 | |
| 2024-12-18 | Agios Pharmaceuticals, Inc. | $30 | Food and Beverage | In-kind items and services | PYRUKYND Drug, Genetically Defined Disease | 2024 | |
| 2024-12-17 | Lilly USA, LLC | $107 | Education | In-kind items and services | 2024 | ||
| 2024-12-16 | Lilly USA, LLC | $30 | Food and Beverage | In-kind items and services | VERZENIO Drug, Oncology | 2024 | |
| 2024-12-12 | Bayer Healthcare Pharmaceuticals Inc. | $30 | Food and Beverage | In-kind items and services | Nubeqa Drug, Oncology | 2024 | |
| 2024-12-04 | Celgene Corporation | $24 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2024 | |
| 2024-12-03 | AstraZeneca Pharmaceuticals LP | $3,015 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-12-03 | AstraZeneca Pharmaceuticals LP | $2,345 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-12-02 | Eisai Inc. | $24 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2024 | |
| 2024-11-25 | PUMA BIOTECHNOLOGY, INC. | $19 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-11-19 | TAIHO ONCOLOGY, INC. | $19 | Food and Beverage | In-kind items and services | LONSURF Drug, Oncology | 2024 | |
| 2024-11-18 | Novartis Pharmaceuticals Corporation | $30 | Food and Beverage | In-kind items and services | Fabhalta Drug, Immunology | 2024 | |
| 2024-11-15 | BeiGene USA, Inc. | $1,950 | Consulting Fee | Cash or cash equivalent | BRUKINSA Drug, Oncology | 2024 | |
| 2024-11-15 | Gilead Sciences, Inc. | $21 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-11-11 | Mirati Therapeutics, Inc. | $20 | Food and Beverage | Cash or cash equivalent | KRAZATI Drug, Oncology | 2024 | |
| 2024-11-08 | Merck Sharp & Dohme LLC | $17 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2024 | |
| 2024-11-07 | BeiGene USA, Inc. | $18 | Food and Beverage | In-kind items and services | TEVIMBRA Drug, Oncology | 2024 | |
| 2024-11-06 | Novartis Pharmaceuticals Corporation | $34 | Food and Beverage | In-kind items and services | Fabhalta Drug, Immunology | 2024 | |
| 2024-11-04 | AstraZeneca Pharmaceuticals LP | $336 | Travel and Lodging | In-kind items and services | IMFINZI Biological, Oncology | 2024 | |
| 2024-11-04 | AstraZeneca Pharmaceuticals LP | $40 | Food and Beverage | Cash or cash equivalent | IMFINZI Biological, Oncology | 2024 | |
| 2024-11-04 | AstraZeneca Pharmaceuticals LP | $29 | Travel and Lodging | In-kind items and services | IMFINZI Biological, Oncology | 2024 | |
| 2024-11-04 | AstraZeneca Pharmaceuticals LP | $21 | Travel and Lodging | Cash or cash equivalent | IMFINZI Biological, Oncology | 2024 | |
| 2024-11-02 | Daiichi Sankyo Inc. | $525 | Consulting Fee | Cash or cash equivalent | ENHERTU Drug, ONCOLOGY | 2024 | |
| 2024-11-02 | AstraZeneca Pharmaceuticals LP | $336 | Travel and Lodging | In-kind items and services | TAGRISSO Drug, Oncology | 2024 | |
| 2024-11-02 | AstraZeneca Pharmaceuticals LP | $50 | Food and Beverage | In-kind items and services | TAGRISSO Drug, Oncology | 2024 | |
| 2024-11-02 | AstraZeneca Pharmaceuticals LP | $29 | Travel and Lodging | In-kind items and services | TAGRISSO Drug, Oncology | 2024 | |
| 2024-11-02 | AstraZeneca Pharmaceuticals LP | $29 | Travel and Lodging | Cash or cash equivalent | TAGRISSO Drug, Oncology | 2024 | |
| 2024-10-30 | Novartis Pharmaceuticals Corporation | $27 | Food and Beverage | In-kind items and services | PLUVICTO Drug, Oncology | 2024 | |
| 2024-10-28 | Regeneron Healthcare Solutions, Inc. | $36 | Food and Beverage | In-kind items and services | LIBTAYO Biological, ONCOLOGY | 2024 | |
| 2024-10-23 | Acrotech Biopharma Inc. | $16 | Food and Beverage | In-kind items and services | BELEODAQ Drug, ONCOLOGY | 2024 | |
| 2024-10-21 | Novartis Pharmaceuticals Corporation | $31 | Food and Beverage | In-kind items and services | Fabhalta Drug, Immunology | 2024 | |
| 2024-10-21 | E.R. Squibb & Sons, L.L.C. | $26 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2024 | |
| 2024-10-20 | Janssen Biotech, Inc. | $32 | Food and Beverage | In-kind items and services | RYBREVANT Drug, Oncology | 2024 | |
| 2024-10-14 | PFIZER INC. | $27 | Food and Beverage | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2024 | |
| 2024-10-12 | AstraZeneca Pharmaceuticals LP | $34 | Food and Beverage | In-kind items and services | IMFINZI Biological, Oncology | 2024 | |
| 2024-10-09 | Regeneron Healthcare Solutions, Inc. | $31 | Food and Beverage | In-kind items and services | LIBTAYO Biological, ONCOLOGY | 2024 | |
| 2024-10-07 | E.R. Squibb & Sons, L.L.C. | $17 | Food and Beverage | Cash or cash equivalent | ELIQUIS Drug, Cardiovascular | 2024 | |
| 2024-09-30 | PFIZER INC. | $37 | Food and Beverage | In-kind items and services | ELREXFIO Drug, ONCOLOGY | 2024 | |
| 2024-09-27 | SERVIER PHARMACEUTICALS LLC | $13 | Food and Beverage | In-kind items and services | Tibsovo Drug, Oncology | 2024 | |
| 2024-09-26 | Daiichi Sankyo Inc. | $29 | Food and Beverage | In-kind items and services | INJECTAFER Drug, Iron Deficiency Anemia | 2024 | |
| 2024-09-13 | E.R. Squibb & Sons, L.L.C. | $24 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2024 | |
| 2024-09-09 | E.R. Squibb & Sons, L.L.C. | $27 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2024 | |
| 2024-09-06 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | VENCLEXTA Drug, ONCOLOGY | 2024 | |
| 2024-09-06 | Tempus AI, Inc | $19 | Food and Beverage | In-kind items and services | XT CDX Device, NONE | 2024 | |
| 2024-09-04 | Merck Sharp & Dohme LLC | $27 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2024 | |
| 2024-09-03 | PFIZER INC. | $21 | Food and Beverage | In-kind items and services | OXBRYTA Drug, HEMATOLOGY | 2024 | |
| 2024-08-30 | Janssen Biotech, Inc. | $26 | Food and Beverage | In-kind items and services | DARZALEX Biological, Oncology | 2024 | |
| 2024-08-23 | Novartis Pharmaceuticals Corporation | $31 | Food and Beverage | In-kind items and services | MEKINIST Drug, Oncology | 2024 | |
| 2024-08-21 | Takeda Pharmaceuticals U.S.A., Inc. | $41 | Food and Beverage | In-kind items and services | FRUZAQLA Drug, ONCOLOGY | 2024 | |
| 2024-08-19 | Daiichi Sankyo Inc. | $29 | Food and Beverage | In-kind items and services | Enhertu Drug, ONCOLOGY | 2024 | |
| 2024-08-12 | Amgen Inc. | $19 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2024 | |
| 2024-07-31 | Kite Pharma, Inc. | $23 | Food and Beverage | In-kind items and services | Yescarta Drug, CELLT | 2024 | |
| 2024-07-30 | Alnylam Pharmaceuticals Inc. | $17 | Food and Beverage | In-kind items and services | GIVLAARI Drug, Genetic Disease | 2024 | |
| 2024-07-24 | ADC THERAPEUTICS AMERICA, INC. | $19 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-07-22 | Pharmacosmos Therapeutics Inc. | $29 | Food and Beverage | In-kind items and services | MONOFERRIC Drug, HEMATOLOGY | 2024 | |
| 2024-07-19 | PFIZER INC. | $24 | Food and Beverage | In-kind items and services | OXBRYTA Drug, HEMATOLOGY | 2024 | |
| 2024-07-17 | Exelixis Inc. | $19 | Food and Beverage | In-kind items and services | CABOMETYX Drug, Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | 2024 | |
| 2024-07-15 | ABBVIE INC. | $28 | Food and Beverage | In-kind items and services | ELAHERE Drug, ONCOLOGY | 2024 | |
| 2024-07-12 | PUMA BIOTECHNOLOGY, INC. | $16 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-07-10 | Genentech USA, Inc. | $22 | Food and Beverage | In-kind items and services | Gazyva Biological, BioOncology | 2024 | |
| 2024-07-08 | ARRAY BIOPHARMA INC | $24 | Food and Beverage | In-kind items and services | LORBRENA Drug, ONCOLOGY | 2024 | |
| 2024-07-03 | PFIZER INC. | $25 | Food and Beverage | In-kind items and services | OXBRYTA Drug, HEMATOLOGY | 2024 | |
| 2024-06-28 | ABBVIE INC. | $32 | Food and Beverage | In-kind items and services | IMBRUVICA Drug, ONCOLOGY | 2024 | |
| 2024-06-26 | Gilead Sciences, Inc. | $26 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-06-18 | Karyopharm Therapeutics Inc. | $33 | Food and Beverage | In-kind items and services | XPOVIO Drug, Oncology | 2024 | |
| 2024-06-14 | Genentech USA, Inc. | $22 | Food and Beverage | In-kind items and services | Gazyva Biological, BioOncology | 2024 | |
| 2024-06-13 | Lilly USA, LLC | $31 | Food and Beverage | In-kind items and services | VERZENIO Drug, Oncology | 2024 | |
| 2024-06-10 | Genentech USA, Inc. | $22 | Food and Beverage | In-kind items and services | Phesgo Biological, BioOncology | 2024 | |
| 2024-05-30 | ABBVIE INC. | $31 | Food and Beverage | In-kind items and services | IMBRUVICA Drug, ONCOLOGY | 2024 | |
| 2024-05-15 | Coherus Oncology, Inc. | $20 | Food and Beverage | In-kind items and services | Udenyca Biological, Granulocyte colony stimulating factor | 2024 | |
| 2024-05-15 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | EPKINLY Drug, ONCOLOGY | 2024 | |
| 2024-05-13 | Janssen Biotech, Inc. | $14 | Food and Beverage | In-kind items and services | CARVYKTI Drug, Oncology | 2024 | |
| 2024-05-08 | E.R. Squibb & Sons, L.L.C. | $27 | Food and Beverage | Cash or cash equivalent | AUGTYRO Drug, Oncology | 2024 | |
| 2024-05-07 | Daiichi Sankyo Inc. | $21 | Food and Beverage | In-kind items and services | Enhertu Drug, ONCOLOGY | 2024 | |
| 2024-04-25 | Novartis Pharmaceuticals Corporation | $27 | Food and Beverage | In-kind items and services | MEKINIST Drug, Oncology | 2024 | |
| 2024-04-24 | Merck Sharp & Dohme LLC | $31 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2024 | |
| 2024-04-22 | Gilead Sciences, Inc. | $25 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-04-18 | Ipsen Biopharmaceuticals, Inc | $25 | Food and Beverage | In-kind items and services | Onivyde Drug, Oncology | 2024 | |
| 2024-04-17 | AstraZeneca Pharmaceuticals LP | $19 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-04-15 | Genentech USA, Inc. | $22 | Food and Beverage | In-kind items and services | Columvi Biological, BioOncology | 2024 | |
| 2024-04-13 | PFIZER INC. | $657 | Travel and Lodging | In-kind items and services | OXBRYTA Drug, HEMATOLOGY | 2024 | |
| 2024-04-13 | PFIZER INC. | $387 | Travel and Lodging | In-kind items and services | OXBRYTA Drug, HEMATOLOGY | 2024 |
The latest 200 records of 635.
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2025-12-31 | AstraZeneca Pharmaceuticals LP | MARYLAND ONCOLOGY HEMATOLOGY COLUMBIA | $5,000 | A Phase III, Randomised, Open-Label, Multicentre Study of Datopotamab Deruxtecan or Docetaxel in Previously Treated TROP | 2025 |
| 2025-10-15 | Celgene Corporation | Maryland Oncology Hematology, Pa | $20,714 | A Phase 3, Two-stage, Randomized, Multi-center, Controlled, Open-label Study Comparing Iberdomide Maintenance to Lenalid | 2025 |
| 2025-05-12 | Celgene Corporation | US ONCOLOGY RESEARCH LLC | $3,272 | A Phase 3, Two-stage, Randomized, Multi-center, Controlled, Open-label Study Comparing Iberdomide Maintenance to Lenalid | 2025 |
| 2025-04-15 | E.R. Squibb & Sons, L.L.C. | Maryland Oncology Hematology, Pa | $28,865 | A Phase 3, Two-stage, Randomized, Multi-center, Controlled, Open-label Study Comparing Iberdomide Maintenance to Lenalid | 2025 |
| 2025-02-25 | E.R. Squibb & Sons, L.L.C. | Maryland Oncology Hematology Clinton | $7,098 | A Phase 3, Two-stage, Randomized, Multi-center, Controlled, Open-label Study Comparing Iberdomide Maintenance to Lenalid | 2025 |
| 2025-01-15 | E.R. Squibb & Sons, L.L.C. | Maryland Oncology Hematology, Pa | $935 | A Phase 3, Two-stage, Randomized, Multi-center, Controlled, Open-label Study Comparing Iberdomide Maintenance to Lenalid | 2025 |
| 2025-01-08 | Celgene Corporation | US Oncology Research | $68,660 | A Phase 3, Two-stage, Randomized, Multi-center, Controlled, Open-label Study Comparing Iberdomide Maintenance to Lenalid | 2025 |
| 2024-08-27 | E.R. Squibb & Sons, L.L.C. | Maryland Oncology Hematology Clinton | $1,922 | Ph III Iberdomide vs. Revlimid post ASCT Maintenance NDMM TE | 2024 |
| 2024-08-07 | Celgene Corporation | US Oncology Research | $13,900 | Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants | 2024 |
| 2024-07-15 | Celgene Corporation | Maryland Oncology Hematology, Pa | $1,870 | Ph III Iberdomide vs. Revlimid post ASCT Maintenance NDMM TE | 2024 |
| 2024-07-10 | E.R. Squibb & Sons, L.L.C. | Us Oncology Res Llc | $3,700 | A Phase 3, Randomized, Double-Blind Study of Nivolumab or Placebo in Combination With Docetaxel, in Men With Metastatic | 2024 |
| 2023-08-28 | E.R. Squibb & Sons, L.L.C. | Maryland Oncology Hematology Clinton | $1,631 | Ph III Iberdomide vs. Revlimid post ASCT Maintenance NDMM TE | 2023 |
| 2023-02-02 | E.R. Squibb & Sons, L.L.C. | Us Oncology Res Llc | $3,300 | A Phase 3, Randomized, Double-Blind Study of Nivolumab or Placebo in Combination With Docetaxel, in Men With Metastatic | 2023 |
| 2023-01-15 | AstraZeneca Pharmaceuticals LP | MARYLAND ONCOLOGY HEMATOLOGY COLUMBIA | $187 | A Retrospective Analysis of Biomarker Testing Variance and Treatment Patterns among Patients with Metastatic Non-Small C | 2023 |
| 2023-01-15 | E.R. Squibb & Sons, L.L.C. | Maryland Oncology Hematology, Pa | $1,870 | Phase III Randomized Study of Opdivo+Doc vs Doc in chemo-nave mCRPC | 2023 |
| 2022-02-15 | E.R. Squibb & Sons, L.L.C. | Maryland Oncology Hematology, Pa | $3,745 | Phase III Randomized Study of Opdivo Doc vs Doc in chemo-nave mCRPC | 2022 |
| 2022-01-27 | E.R. Squibb & Sons, L.L.C. | Us Oncology Res Llc | $19,935 | A Phase 3, Randomized, Double-Blind Study of Nivolumab or Placebo in Combination With Docetaxel, in Men With Metastatic | 2022 |
| 2022-01-15 | Eli Lilly and Company | MARYLAND ONCOLOGY HEMATOLOGY PA | $2,868 | EMONARCHER: A RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF ABEMACICLIB PLUS STANDARD ADJUVANT ENDOCRINE | 2022 |
| 2021-10-15 | Eli Lilly and Company | MARYLAND ONCOLOGY HEMATOLOGY PA | $10,200 | EMONARCHER: A RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF ABEMACICLIB PLUS STANDARD ADJUVANT ENDOCRINE | 2021 |
| 2021-02-18 | E.R. Squibb & Sons, L.L.C. | Us Oncology Res Llc | $43,975 | A Phase 3, Randomized, Double-Blind Study of Nivolumab or Placebo in Combination With Docetaxel, in Men With Metastatic | 2021 |
| 2021-02-15 | E.R. Squibb & Sons, L.L.C. | Maryland Oncology Hematology, Pa | $38,923 | Phase III Randomized Study of Opdivo Doc vs Doc in chemo | 2021 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Brandywine, MD, county Prince George's County, MD, state Maryland; placed by its city name.
| Measure | Place (city or town) Brandywine, MD | County Prince George's County, MD | State Maryland |
|---|---|---|---|
| Population B01003 | 12,160 | 959,754 | 6,206,011 |
| Population, 2020 census P1 | 10,550 | 967,201 | 6,177,224 |
| Median age B01002 | 44.0 | 38.5 | 39.4 |
| Under 18 B01001 | 18.2% | 22.1% | 22.2% |
| 65 and over B01001 | 13.7% | 14.9% | 16.7% |
| Households B11001 | 4,149 | 347,744 | 2,362,928 |
| Foreign born B05002 | 7.0% | 25.3% | 16.6% |
| Median household income B19013 | $157,587 | $101,798 | $103,678 |
| Median family income B19113 | $179,419 | $120,601 | $127,817 |
| Per capita income B19301 | $62,060 | $46,366 | $52,979 |
| Poverty rate B17001 | 6.2% | 10.8% | 9.4% |
| Unemployment rate B23025 | 5.6% | 6.4% | 4.9% |
| Civilian labor force B23025 | 7,240 | 531,986 | 3,313,651 |
| Mean commute (minutes) B08013 | 41.5 | 35.2 | 31.1 |
| Bachelor's degree or higher B15003 | 38.8% | 36.7% | 43.4% |
| Housing units B25001 | 4,215 | 365,506 | 2,560,784 |
| Owner-occupied B25003 | 95.9% | 62.3% | 67.6% |
| Renters B25003 | 4.1% | 37.7% | 32.4% |
| Median home value B25077 | $551,000 | $426,000 | $419,900 |
| Median gross rent B25064 | $2,757 | $1,799 | $1,705 |
| White, not Hispanic B03002 | 10.6% | 10.8% | 46.6% |
| Black B03002 | 78.3% | 58.2% | 28.9% |
| Hispanic or Latino B03002 | 5.1% | 22.5% | 12.5% |
| Asian B03002 | 1.2% | 3.9% | 6.5% |
| American Indian and Alaska Native B03002 | 0.0% | 0.1% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Brandywine, MD.
Comments